1.              

Verorab

Rabies Virus

Vaccine

102-2402-91

Sanofi Pasteur S A  ,France

05.05.2024

Sanofi Bangladesh Limited., Dhaka

2.              

Rabipur®

Rabies Virus 2.5 IU

Injectable

Vaccine

108-2618-94

Chiron Behring Vaccine Pvt. Ltd.,

06.11.2019

Renata Ltd, Dhaka

3.              

Human Antitetanus Immune Globulin Grifols 250 IU Injection

Human Antitetanus Immune Globulin 250 IU

Injectable

Vaccine

166-2664-95

Instituto Grifols S.A., Spain

08.05.2010

Shuvro Ltd, Dhaka

4.              

Engerix-B

Hepatitis B Vaccine

Vaccine

62-2499-94

Glaxo Smith Kline Bioglan SA, Belgium

12.06.2018

GlaxoSmith Kline Bangladesh Ltd., Dhaka

5.              

Hepavax Gene

Hepatitis B Vaccine

Vaccine

221-2830-96

Berna Biotech, Korea

13.03.2011

Healthcare Marketing Ltd Dhaka

6.              

Hepavax Gene

Hepatitis B Vaccine

Vaccine

221-2832-96

Berna Biotech, Korea

13.03.2011

Healthcare Marketing Ltd Dhaka

7.              

Maningococcal Polysaccharide Vaccine A+C

Maningococcal Polysaccharide Vaccine A+C

Vaccine

102-2841-96

Pasteur Merieux Serums and Vaccines, France

11.05.2016

Sanofi Bangladesh Limited., Dhaka

8.              

Trimovax Injection

Vaccinum Morbillorum Vivum, measles, mumps, rubella 

Vaccine

102-2992-97

Sanofi Pasteur SA, France

26.04.2017

Sanofi Bangladesh Limited., Dhaka

9.              

Varilrix Vaccine

Live Attenuated Varicella Virus Vaccine OKA Strain

Vaccine

229-3156-97

Glaxo Smith Kline Biologicals S.A., Belgium

15.10.2017

GlaxoSmith Kline Bangladesh Ltd., Dhaka

10.            

Priorix Vaccine

Live Attenuated mumps, Rubella, Measles Vaccine

 Injectable vaccine

229-3270-98

Glaxo Smith Kline Biologicals S.A, Belgium

17.05.2018

GlaxoSmith Kline Bangladesh Ltd., Dhaka

11.            

Act-HIB

Haemophilus Influenzae Type B Polysaccjarode 10 ug/dose

Injectable

Vaccine

107-3173-97

Sanofi Pasteur S A, France

28.10.2017

Sanofi Bangladesh Limited., Dhaka

12.            

Typhim VI

Purified Vi capsular polysaccharide of salmonella Typhi (Ty 2 strain) 0.025 mg/dose

Injectable

Vaccine

102-3177-97

Sanofi Pasteur S A, France

05.05.2024

Sanofi Bangladesh Limited., Dhaka

13.            

Hiberix Vaccine

Haemophilus Infulenzae Type B Vaccine

Vaccine

229-3350-98

Glaxo Smith Kline Biological S.A., Belgium

01.09.2018

GlaxoSmith Kline Bangladesh Ltd., Dhaka

14.            

Typherix

Polysaccharide  25ug/0.5ml P.F.S

Injectable

Vaccine

229-3551-00

Glaxo Smithkline Biologicals S.A., Belgium

02.04.2020

GlaxoSmith Kline Bangladesh Ltd., Dhaka

15.            

Havrix 1440

HAV Antigen

(Hepatits A Vaccine)

Injectable

Vaccine

229-3622-01

Glaxo Smith Kline Biologicals S.A., Belgium

15.04.2021

GlaxoSmith Kline Bangladesh Ltd., Dhaka

16.            

Havrix 720

HAV Antigen

(Hepatits A Vaccine)

Injectable

Vaccine

229-3623-01

Glaxo Smith Kline Biologicals S.A., Belgium

15.04.2021

GlaxoSmith Kline Bangladesh Ltd., Dhaka

17.            

Inj. Tetabulin

(Tetanus Immunoglobulin Human 250IU)

Tetanus Antitoxin 250IU

Injectable

Vaccine

191-3672-01

Baxter AG, Austria

09.12.2011

Swadesh, Dhaka

18.            

Tritanrix HB

Diphtheria Toxoid  30IU

Tetanus Toxoid 60 IU

Inactivated Bordetella Pertussis 4 IU

r-DNA HBs AG 10mcg

Injectabe

Vaccine

105-3681-01

Glaxo Smithkline Biologicals, Belgium

28.12.2016

GlaxoSmith Kline Bangladesh Ltd., Dhaka

19.            

Avaxim, Inactivated Hepatitis A Vaccine

Inactivated Hepatitis A Virus

Injectable Vaccine

102-3796-2004

 Sanofi Pasteur S.A., France

16.01.2019

Sanofi Bangladesh Limited., Dhaka

20.            

Avaxim 80 IU Pediatric

Inactivated Hepatitis A Virus Ph. Eur. 80 antigen units

Injectable

Vaccine

102-3931-2004

Aventis Pasteur S.A., France

19.06.2019

Sanofi Bangladesh Limited., Dhaka

21.            

Mencevax ACWY Vaccine

Meningococcal polysaccharide Serogroup A Ph. Eur 50 mcg

Meningococcal polysaccharide Serogroup C Ph. Eur 50 mcg

Meningococcal polysaccharide Serogroup W135 Ph Eur 50 mcg

Meningococcal polysaccharide Serogroup y Ph Eur 50 mcg

Injectable

Vaccine

105-3956-2004

Glaxo SmithKline Biological S.A., Belgium

24.10.2019

GlaxoSmith Kline Bangladesh Ltd., Dhaka

22.            

Imovax Polio Injection

Inactivated Poliovirus Type-1 Ph. Eur 40 antigen D unit

Inactivated Poliovirus Type-2 Ph. Eur 8 antigen D Unit

Inactivated Poliovirus Type-3 Ph. Eur 32 antigen D unit

Injectable

Vaccine

102-3978-2005

Sanofi Aventis Pasteur SA, France

24.01.2020

Sanofi Bangladesh Limited., Dhaka

23.            

Pentaxim

Diptheria Toxoid 30 IU

Tetanus Toxoid 40 IU

Bordetella Pertusis Antigens Toxoid 25 mcg

Filamentous Haemagglutinin 25 mcg

Inactivated Type 1 Poliomyelitis Virus 40 DU

Inactivated Type 2 Poliomylities Virus 8 DU

Inactivated Type 3 Poliomyelitis Virus 32 DU

Haemophilus Influenzae type B Poliomyelitis virus 10 mcg/ Prefilled syringe

Injectable Vaccine

102-4152-2006

 Sanofi Pasteur, France

04.02.2021

Sanofi Bangladesh Limited.,

24.            

Vaxem HIB 0.5

Haemophilus Influenza Type B Vaccine Ph. Eur 10 mcg/5 ml

Injectable Vaccine

125-4182-2006

Novartis Vaccines and Diagnostics, Italy

01.04.2011

Novartis Bangladesh Ltd., Dhaka

25.            

Fluarix Vaccine

A/New Caledonia/20/90 (HINI) Like Strain Ph. Eur 15 mcg

A/California/7/2004 (H3N2) like strain Ph. Eur. 15 mcg

B/Shanghai/361/2002-like strain Ph. Eur. 15 mcg/dose

Injectable

Vaccine

105-4201-2006

GlaxoSmithKline Biologicals, Germany

28.12.2021

GlaxoSmith Kline Bangladesh Ltd., Dhaka

26.            

Rotarix Vaccine

Human Rota Virus, live attenuated Rix4414 Strain INN Not less than 10^6.0 CCID₅₀

Injectable

Vaccine

105-4202-2006

GlaxoSmithKline Biologicals SA, Belgium

28.12.2021

GlaxoSmith Kline Bangladesh Ltd., Dhaka

27.            

Infanrix hexa

Diptheria Toxoid (D) min 30IU+Tetanus Toxid (T) min 40IU+ Pertusis Toxoid (PT) 25mcg+Filamentous hemagglutinin (FHA) 25mcg+ Pertactin (69kDa outer memberanc Protein 8mcg + r-DNA Hepatitis B surface antigen (HBsAg) 10mcg+ Inactivated Plolio Virus (IPV) Type 1  40DU+ Inactivated Plolio Virus (IPV) Type 2  8DU + Inactivated Plolio Virus (IPV) Type 3  32DU/0.5ml

Injectable vaccine

105-4256-2008

GlaxoSmithkline Biologicals S.A, Belgium

08.09.2018

GlaxoSmith Kline Bangladesh Ltd., Dhaka

28.            

Cervarix

Human Papillomavirus type 16 L1 Protein¹  20mcg +Human Papillomavirus type 18 L1 Protein¹  20mcg /0.5ml

Injectable vaccine

105-4257-2008

GlaxoSmithkline Biologicals S.A, Belgium

08.09.2018

GlaxoSmith Kline Bangladesh Ltd., Dhaka

29.            

Favirab

F(ab’)2 Fragment of equine antirabes immune globulin/ml 200-400 IU

Vaccine

102-4262-2008

Aventis Pasteur, France

01.11.2018

Sanofi Bangladesh Limited., Dhaka

30.            

Okavax 

An attenuated live Varicella-zoster Virus 1400 PFU+ Sodium Chloride 1.6mg+Potassium Chloride 0.04mg+Monobasic Potassium Phosphate 0.4mg+ Dibasic Sodium Phosphate hydrate 4.395mg+Sucrose 35mg+Monosodium L-glutamate monohydrate 0.5mg+Kanamycin Sulfate 10mcg (potency)+Erythromycin lactobionate 3mcg (potency) /0.7ml

Injectable

Vaccine

102-4414-2009

The Research Foundation for Microbial Disease of Osaka University, Japan

21.06.2014

Sanofi Bangladesh Limited., Dhaka

31.            

TETRAct-HIB

Haemophilus Influenza type b polysaccharide conjugated to tetanus Protein 10mcg+Purified diphtheria toxoid 30IU+Purified tetanus toxoid 60IU+Bordetella pertussis 4IU/0.5ml

Injectable

Vaccine

102-4415-2009

Sanofi Pasteur SA, France

21.06.2014

Sanofi Bangladesh Limited., Dhaka

32.            

Rotarix

Human Rota Virus, Live attenuated, RIX 4414 Strain Not less than 10⁶  CCID₅₀/ 1.5ml

Oral Vaccine

105-4470-2010

GlaxoSmithKline Biologicals S.A, Belgium

27.01.2021

Sanofi Bangladesh Limited., Dhaka

33.            

Pneumo-23

Purified capsular polysaccharides of Streptococcus pneumoniae 1,2,3,4,5.6B, 7F,8,9N,9V,10A, 11A,12F,14, 15B,17F, 18C, 19A,19F,20,22F,23F, 33F for Each of the 23 serotypes 25mcg/ 0.5ml in P.F.S

Injectable

Vaccine

102-4473-10

Sanofi Pasteur SA , France

15.02.2020

Sanofi Bangladesh Limited., Dhaka

34.            

Vaxigrip

A.Brisbane/59/2007(H1N1) 15mcgHA+ A/Brisbane/10/2007(H3N2) 15mcgHA+ B/Florida/4/2006 15mcgHA/0.5ml in P.F.S

Injectable

Vaccine

102-4474-10

Sanofi Pasteur SA, France

15.02.2025

Sanofi Bangladesh Limited., Dhaka

35.            

Tetraxim

Diphtheria Toxoid ≥ 30 IU+ Tetanus Toxoid ≥ 40 IU

Bordetella Pertussis antigens:

Toxoid 25µg+ Filamentous haemagglutinin +25µg+ Inactivated type 1 Poliomyelitis virus+40DU*†+ Inactivated type 2 Poliomyelitis virus + 8DU*†+ Inactivated type 3 Poliomyelitis virus+ 32 DU*†

*DU: antigen D unit

† or eq. antigenic quantity determined by a suitable immunochemical method

Injectabe Vaccine

102-4649-011

Sanofi Pasteur, France

18.05.2016

Sanofi Bangladesh Limited., Dhaka

36.            

Stamaril

Yellow fever Virus 17 D-204 Strain (Live attenuated) ≥ 1000 LD₅₀ units

Injectabe Vaccine

102-4650-011

Sanofi Pasteur, France

15.05.2021

Sanofi Bangladesh Limited., Dhaka

37.            

Synflorix

Pnenmococcal Polysaccharide Serotype 1 ^1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 4 ^1.2 INN 3mcg+ Pnenmococcal Polysaccharide Serotype 5 ^1.2 INN 1mcg + Pnenmococcal Polysaccharide Serotype 6B ^1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 7F ^1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 9V ^1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 14 ^1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 18C ^1.3 INN 3mcg + Pnenmococcal Polysaccharide Serotype 19F ^1.4 INN 3mcg+ Pnenmococcal Polysaccharide Serotype 23F ^1.2 INN 1mcg+ ¹adsorbed on aluminium phosphate 0.5mg Al³+ ²Conjugated to protein D (derved from non-typeaable Haemophilus influenzae) Carrier protein 9-16mcg ³Conjugated to tetanus toxoid carrier protein 5-10mcg ⁴Conjugated to diphtheria toxoid carrier protein 3-6mcg/0.5ml

Injectable

Vaccine

105-4663-011

GlaxoSmithkline Biological s.a. Belgium

20.07.2021

GlaxoSmith Kline Bangladesh Ltd., Dhaka

38.            

BCG-Medac

Bacillus calmette-Guerin strain (seed RIVM derived from Seed 1173-p2) at least 2x10⁸ and not more than 2x10⁹  Viable units

Injectable Vaccine

221-4684-001

Medac Gesellschaft fur Klinische spezialpraparate Germany

12.11.2021

Tajarat Healthcare marketing Ltd, Dhaka

39.            

Prevenar 13

Pneumococcal Polysaccharide serotype 1  2.2µg +

Pneumococcal Polysaccharide serotype 3  2.2µg + Pneumococcal Polysaccharide serotype 4  2.2µg + Pneumococcal Polysaccharide serotype 5  2.2µg + Pneumococcal Polysaccharide serotype 6A  2.2µg + Pneumococcal Polysaccharide serotype 6B  4.4µg + Pneumococcal Polysaccharide serotype 7F  2.2µg + Pneumococcal Polysaccharide serotype 9V  2.2µg + Pneumococcal Polysaccharide serotype 14  2.2µg + Pneumococcal Polysaccharide serotype 18C 2.2µg + Pneumococcal Polysaccharide serotype 19A  2.2µg + Pneumococcal Polysaccharide serotype 19F  2.2µg + Pneumococcal Polysaccharide serotype 23F  2.2µg

Injectable Vaccine

213-4690-011

Jhon Wyeth & Brother Ltd. UK and Marketing Authorisation Holder Wyeth Lederle Vaccine SA Belgium

26.11.2021

Janata Traders, Dhaka

40.            

Vaxigrip Enfants

A/California/7/2009(H1N1)-derived Strain Used NYMC X-179A 7.5 Micrograms HA**+ A/Perth/16/2009 (H3N2)-Like strain used NYMC X-187 Derived from A/Victoria/210/2009                7.5 Micrograms HA**+ B/Brisbane/60/2008 7.5 Micrograms HA**

Per 0.25ml dose

Injectable Vaccine

102-4732-012

Sanofi Pasteur SA, , France

02.02.2017

Sanofi Bangladesh Limited., Dhaka

41.            

Td-Pur

purified tetanus Toxide Concentrate Nol Less than 20IU+ purified Diphtheria Toxide Concentrate Nol Less than 2IU/0.5ml

Injectable Vaccine

236-4744-012

Novartis Vaccine and Diagnostics Germany

01.02.2017

GlaxoSmith Kline Bangladesh Ltd., Dhaka

42.            

Menveo

Meningococcal group A oligosacchardi conjugated to corynebacterium diphtheriae GRM 197Protein (Contained in the Powder 10.00mcg (16.7 to 33.3mcg) + Meningococcal group C oligosacchardi conjugated to corynebacterium diphtheriae GRM197 Protein (Contained in the Solution 5.00mcg (7.1 to 12.5mcg)+ Meningococcal group W-135 oligosacchardi conjugated to corynebacterium diphtheriae GRM197Protein (Contained in the Solution 5.00mcg (3.3 to8.3mcg)+ Meningococcal group Y oligosacchardi conjugated to corynebacterium diphtheriae GRM 197 Protein (Contained in the Solution 5.00mcg (5.6 to 10.0mcg)

Injectable Vaccine

236-4743-012

Novartis Vaccine and Diagnostics Germany

21.02.2022

GlaxoSmith Kline Bangladesh Ltd., Dhaka

43.            

MENUMONE-A/C/Y/W-135

Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. W-135 50µg/1.5ml Vial

Injection

102-4779-13

Sanofi Pasteur Inc., USA

04.02.2018

Sanofi Bangladesh Limited., Dhaka

44.            

MENUMONE-A/C/Y/W-135

Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. W-135 50µg/1.5ml Vial

Injection

102-4780-13

Sanofi Pasteur Inc., USA

04.02.2018

Sanofi Bangladesh Limited., Dhaka

45.            

Tetanol pur

Purified Tetanus Toxoid

Vaccine

236-4702-011

GP Grenzach Produktions Gmbh, Germany

10.12.2016

GlaxoSmith Kline Bangladesh Ltd., Dhaka

46.            

GARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine)

Type 6L1 protein INN 20 µg

Type 11L1 protein INN 40 µg

Type 16L1 protein INN 40 µg

Type 18L1 protein INN 20 µg

Suspension for Injection

213-4858-14

Merck Sharp & Dohme Corp., USA

27.04.2024

Healthcare Pharmaceutical Ltd, Dhaka

47.            

RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent)

G1 Reassortant INN ≥2.2 x 10⁶ IU/Dose

G2 Reassortant INN ≥2.8 x 10⁶ IU/Dose

G3 Reassortant INN ≥2.2 x 10⁶ IU/Dose

G4 Reassortant INN ≥2.0 x 10⁶ IU/Dose

P1 Reassortant INN ≥2.3 x 10⁶ IU/Dose

Suspension for oral Administration Single Dose

213-4859-14

Merck Sharp & Dohme Corp., USA

27.04.2024

Healthcare Pharmaceutical Ltd, Dhaka

48.            

Pneumovax 23 (Pneumococcal Vaccine Polyvalent)

Pneumococcal Polysaccharide INN 25mcg/dose of each type

Single dose vial

213-4860-14

Merck Sharp & Dohme Corp., USA

27.04.2024

Healthcare Pharmaceutical Ltd, Dhaka

49.            

VARIVAX

Oka/Merck Varicella Virus INN 1350 PFU (Plaque-forming units)

Powder and solvent for suspension for injection

213-5197-016

Merck Sharp & Dohme Corp., USA

27.04.2024

Healthcare Pharmaceutical Ltd, Dhaka

50.            

Vaxigrip Tetra

Quadvivalent Influenza vaccine

-A/Michigan/45/2015 (H1N1) pdm 09-like Strain

(A/Michigan/45/2015, NYMC x-275

-A/Hong Kong/4801/2014 (H3N2)-Like Strain

(A/Hong Kong/4801/2014, NYMC x-263B)

-B/Brishane/60/2008-Like strain

(B/Brisbane/60/2008, wild type)

-B/Phuket/3073/2013-Like strain

(B/Phuket/3073/2013, wild type

Vaccine

97-5892-017

Sanofi Pasteur SA, France

26.02.2022

Sanofi Bangladesh Ltd.

51.            

Nimenrix Powder and Solvent for Solution for Injection in pre-filled syringes.

Neisseria meningitidis group A polysaccharide 5mcg + Neisseria meningitidis group C polysaccharide 5mcg+ Neisseria meningitidis group W-135 polysaccharide 5mcg+ Neisseria meningitidis group Y polysaccharide 5mcg+  Conjugated to tetanus toxoid carrier protein 44mcg

Powder and Solvent for Injection

366-6324-018

Made by GlaxoSmithKline Biologicals S.A., Belgium

for Pfizer Limited, United Kingdom

Batch releasing site:

Pfizer manufacturing Belgium NV, Rijksweg 12, B-2870 Puurs, Belgium

11.04.2026

Radiant Export Import Enterprise, Dhaka

52.            

Prevenar 13

(Vaccine)

Pneumococcal polysaccharide serotype (13-valent, adsorbed)

Suspension for Injection

366-6663-020

Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium.

24.02.2024

Radiant Export Import Enterprise, Dhaka

53.            

Tetraxim

Diphtheria toxoid ≥ 30 IU

Tetanus Toxoid ≥ 40 IU

Bordetella pertussis antigens: Toxoid 25μg

Filamentous haemagglutinin 25μg

Inactivated type 1 Poliomyelitis virus 40DU

Inactivated type 2 Poliomyelitis virus 8DU Inactivated type 3 Poliomyelitis virus 32 DU / 1 dose (0.5 ml)

Suspension for Injection in prefilled syringe

102-6688-020

Manufactured by:

Sanofi Pasteur, Parc Industriel d’Incarville 27100 Val de Reuil France,

Marketing Authorization Holder (MAH):

Sanofi Pasteur, 14 Espace Henry Vallee, 69007 Lyon, France

12.10.2025

Sanofi Bangladesh Limited.,

54.            

Prevenar 13

Pneumococcal Polysaccharide serotype Ph. Eur. 1,3,4,5,6A, 6B, 7F,9V,14,18C,19A,19F,23F

Suspension for Injection

213-6697-2020

Pfizer Ireland Pharmaceuticals, Grange Castle, Business Park Clondalkin, Dublin-22, Ireland (also responsible for quality control and primary packaging) & site responsible for Secondary Packaging & Batch release by Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium

09.12.2025

M/s. Janata Traders, 62/2, Purana Paltan, Dhaka

Date: 10.12.2020

55.            

Nimenrix

Neisseria meningitidis group A polysaccharide  In-House  5mcg + Neisseria meningitidis group C polysaccharide  In-House  5mcg+ Neisseria meningitidis group W-135 polysaccharide  In-House  5mcg+ Neisseria meningitidis group Y polysaccharide  In-House  5mcg+  Conjugated to tetanus toxoid carrier protein 44mcg)

Powder and Solvent for Solution for  Injection in pre-filled syringes

366-6718-2021

Pfizer Manufacturing Belgium NV, Rijksweg 12, B-2870 Puurs, Belgium (also responsible for batch release in the EU, quality control, primary and secondary packaging)

03.04.2026

M/s Radiant Export Import Enterprise,

Date: 04.04.2021